Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 4/20 | 1.00 |
| ▸ | ALOX15 | P16050 | 1/20 | 1.00 |
| ▸ | POLB | P06746 | 3/20 | 0.68 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.60 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.60 |
| ▸ | PPARG | P37231 | 1/20 | 0.40 |
| ▸ | PPARD | Q03181 | 1/20 | 0.40 |
| ▸ | PPARA | Q07869 | 1/20 | 0.40 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.38 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.38 |
| ▸ | CNR2 | P34972 | 1/20 | 0.38 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.38 |
| ▸ | ACHE | P22303 | 1/20 | 0.38 |
| ▸ | DHFR | P00374 | 1/20 | 0.38 |
| ▸ | HTR2A | P28223 | 1/20 | 0.38 |
| ▸ | HTR2C | P28335 | 1/20 | 0.38 |
| ▸ | HTR2B | P41595 | 1/20 | 0.38 |
| ▸ | AR | P10275 | 1/20 | 0.37 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.37 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Apiol SCHEMBL29410305 | 1.00 | CYP3A4 (1.00) | CYP3A4ALOX15POLBALDH1A1SMN1; SMN2 | |
| SCHEMBL3931943 | 0.89 | CYP3A4 (0.80) | CYP3A4ALOX15POLBALDH1A1SMN1; SMN2 | |
| SCHEMBL26060412 | 0.81 | CYP3A4 (0.68) | CYP3A4ALOX15POLBALDH1A1SMN1; SMN2 | |
| SCHEMBL3486950 | 0.81 | POLB (1.00) | CYP3A4ALOX15POLBALDH1A1SMN1; SMN2 | |
| SCHEMBL17778495 | 0.80 | CYP3A4 (0.66) | CYP3A4ALOX15POLBALDH1A1SMN1; SMN2 | |
| SCHEMBL25367786 | 0.80 | CYP3A4 (0.67) | CYP3A4ALOX15POLBALDH1A1SMN1; SMN2 | |
| SCHEMBL25371015 | 0.80 | CYP3A4 (0.67) | CYP3A4ALOX15POLBALDH1A1SMN1; SMN2 | |
| SCHEMBL10539412 | 0.78 | CYP3A4 (0.64) | CYP3A4ALOX15POLBALDH1A1SMN1; SMN2 | |
| Dillapiole SCHEMBL310992 | 0.77 | POLB (0.71) | CYP3A4ALOX15POLBALDH1A1SMN1; SMN2 | |
| SCHEMBL2424490 | 0.77 | POLB (1.00) | CYP3A4ALOX15POLBALDH1A1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 570 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260069551-A1 | Patch for treating demyelinating diseases | UNIV MAINZ JOHANNES GUTENBERG (DE) | 2026-03-12 | — | — | US | claimed |
| US-12514254-B2 | Rosa canina rosehip | UNIVERSITA′ DEGLI STUDI DI CAGLIARI (IT) | 2026-01-06 | — | — | US | claimed |
| EP-4587027-A1 | PATCH FOR TREATING DEMYELINATING DISEASES | Johannes Gutenberg-Universität Mainz (DE) | 2025-07-23 | — | — | EP | claimed |
| US-20240324588-A1 | ESSENTIAL OIL MICROPARTICLES FOR POWDER COATING APPLICATIONS | Genesee Valley Innovations, LLC | 2024-10-03 | — | — | US | claimed |
| WO-2024056642-A1 | PATCH FOR TREATING DEMYELINATING DISEASES | Johannes Gutenberg-Universität Mainz (DE) | 2024-03-21 | — | — | WO | claimed |
| EP-4338740-A1 | A TRANSDERMAL PATCH FOR PROMOTING OR ACCELERATING MYELINATION AND/OR REMYELINATION | Johannes Gutenberg-Universität Mainz (DE) | 2024-03-20 | — | — | EP | claimed |
| US-20240041054-A1 | ROSA CANINA ROSEHIP | UNIVERSITA' DEGLI STUDI DI CAGLIARI (IT) | 2024-02-08 | — | — | US | claimed |
| EP-4294361-A1 | ROSEHIP | UNIVERSITA' DEGLI STUDI DI CAGLIARI (IT) | 2023-12-27 | — | — | EP | claimed |
| CN-110658283-B | Method for detecting volatile components of folium artemisiae argyi | 天津中医药大学 | 2022-11-01 | — | — | CN | claimed |
| WO-2022191398-A1 | METHOD FOR PREPARING INSECTICIDE MASTERBATCH FOR NON-WOVEN FABRIC, INSECTICIDE MASTERBATCH FOR NON-WOVEN FABRIC, NON-WOVEN FABRIC, AND ARTICLE | 도레이첨단소재 주식회사 | 2022-09-15 | — | — | WO | claimed |
| WO-2011092602-A2 | METHODS OF CONTROLLING THE BREEDING BEHAVIOR OF BUTTERFLIES | UNIVERSITY OF THE WEST INDIES, A REGIONAL INSTITUTION, ESTABLISHED BY ROYAL CHARTER (JM) | 2011-08-04 | — | — | WO | claimed |
| EP-1767514-B1 | Process for the isomerisation of alkenylalkoxybenzenen | SYMRISE GMBH & CO KG (DE) | 2010-03-31 | — | — | EP | claimed |
| EP-1793796-B1 | USE OF AROMA SUBSTANCE MIXTURES AS AGENTS AGAINST BAD BREATH | SYMRISE GMBH & CO KG (DE) | 2009-12-09 | — | — | EP | claimed |
| CN-101541318-A | Method for improving bioavailability of renin inhibitor | NOVARTIS AG (CH) | 2009-09-23 | — | — | CN | claimed |
| CN-100448924-C | Preparation for fly-repellent plastic-bottle cap and use in seasoning package product thereof | UNIV HUANAN AGRICULTURE (CN) | 2009-01-07 | — | — | CN | claimed |
| CN-101186772-A | Helminthic emulsion paint and preparation method thereof | UNIV SOUTH CHINA AGRICULT (CN) | 2008-05-28 | — | — | CN | claimed |
| EP-1767514-A1 | Process for the isomerisation of alkenylalkoxybenzenen | Symrise GmbH & Co. KG (DE) | 2007-03-28 | — | — | EP | claimed |
| CN-1709957-A | Preparation for fly-repellent plastic-bottle cap and use in seasoning package product thereof | UNIV HUANAN AGRICULTURE (CN) | 2005-12-21 | — | — | CN | claimed |
| EP-1523896-A1 | Composition for oral ingestion | Cognis Iberia, S.L. (ES) | 2005-04-20 | — | — | EP | claimed |
| US-5720304-A | DIAGNOSIS BY CONVENTIONAL MEDICAL TECHNIQUE OR BI-DIGITAL-O-RING TEST; HAVING PATIENT INGEST ANTIBIOTIC OR ANTIVIRAL AGENT, ALSO INGEST A HERB CONCENTRATION OF UMBELLIFERAE FAMILY OVER SUSTAINED PERIOD OF TIME | OMURA YOSHIAKI (US) | 1998-02-24 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260069551-A1 | Patch for treating demyelinating diseases | PMP22, PLP2, MYT1 | CYP3A4 4770/4885ALOX15 4181/4885POLB 491/4885 |
| US-20240324588-A1 | ESSENTIAL OIL MICROPARTICLES FOR POWDER COATING APPLICATIONS | EXOSC9, EXOSC4, PHOSPHO1 | CYP3A4 4286/4885ALOX15 41/4885POLB 1395/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.